Bioinformatics - A Global Market Intelligence ReportBizAcumen, Inc.November 1, 2009 386 Pages - SKU: BZAC2521912 |
| Countries covered: Global Bioinformatics is a key discipline operating on the forefront of the biotech revolution. Despite dynamic potential, Bioinformatics remains a challenging industry, in part due to its still evolving status. A significant challenge in bioinformatics remains incorporation of different sources into one viable platform for accessing complete data. Also a major concern for this industry is the sheer lack of competent and qualified workforce, particularly for documentation. New tools are not only pushing the development of drug discovery, but also fundamentally changing the nature of biological research. The success of HGP (Human Genome Project) and breakthrough technologies in drug discovery initiatives spells significant investment opportunities for the industry. These and other market data and trends are presented in "Bioinformatics: A World Market Analysis" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses. Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location. The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report. Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. |
More Global Drug Discovery Reports
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition by
Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, ...
Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012 by
GlobalData
Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012 provides data on the Non-Alcoholic Steatohepatitis ...
Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2012 by
GlobalData
Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2012 provides data on the Tachycardia (Tachyarrhythmias) ...
Restless Legs Syndrome Global Clinical Trials Review, H1, 2012 by
GlobalData
Restless Legs Syndrome Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Restless Legs Syndrome Global Clinical Trials Review, H1, 2012 provides data on the ...
Lung Injury Global Clinical Trials Review, H1, 2012 by
GlobalData
Lung Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Lung Injury Global Clinical Trials Review, H1, 2012 provides data on the Lung Injury ...
See all reports like this >>
Related Markets
Drug Discovery Reports
- Biosensors - A Global Market Overview
- Nucleic Acid Therapies in Oncology Drug Pipeline Update 2012
- Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases)
- Synthetic Biology: Emerging Global Markets
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly

